Gentamycin Teaching 1528
SN advised patient to report signs or symptoms or ototoxicity or nephrotoxicity during gentamycin therapy.
Reviewed November 2017
Reviewed for general reference only. Adapt to your patient, agency policy, and scope of practice.
Related teachings
Gentamycin Teaching 1521SN advised patient and caregiver to report any signs and symptoms of ototoxicity or nephrotoxicity. Caregiver verbalizzed understanding of instructions given. Gentamycin Teaching 1522SN instructed patient and caregiver to maintain adequate fluid intake and avoid dehydration during drug therapy, as this may increase risk for toxicity. Caregiver verbalized understanding of instructions given. Gentamycin Teaching 1527SN advised patient on some serious adverse effects of gentamycin such as: neuromuscular blockade finding, ototoxicity, nephrotoxicity, respiratory tract paralysis, concomitant anesthesia, and muscle relaxants. Gentamycin Teaching 1529SN advised patient to maintain adequate fluid intake and avoid dehydration during gentamycin therapy as this may increase risk for toxicity.